4
views
0
recommends
+1 Recommend
2 collections
    0
    shares

      Call for Papers: Supportive Care - Essential for Modern Oncology

      Submit here before December 31, 2024

      About Oncology Research and Treatment: 2.0 Impact Factor I 3.2 CiteScore I 0.521 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Radiogenomic Associations Clear Cell Renal Cell Carcinoma: An Exploratory Study

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction: This study investigates how quantitative texture analysis can be used to non-invasively identify novel radiogenomic correlations with clear cell renal cell carcinoma (ccRCC) biomarkers. Methods: The Cancer Genome Atlas-Kidney Renal Clear Cell Carcinoma open-source database was used to identify 190 sets of patient genomic data that had corresponding multiphase contrast-enhanced CT images in The Cancer Imaging Archive. 2,824 radiomic features spanning fifteen texture families were extracted from CT images using a custom-built MATLAB software package. Robust radiomic features with strong inter-scanner reproducibility were selected. Random forest, AdaBoost, and elastic net machine learning (ML) algorithms evaluated the ability of the selected radiomic features to predict the presence of 12 clinically relevant molecular biomarkers identified from the literature. ML analysis was repeated with cases stratified by stage (I/II vs. III/IV) and grade (1/2 vs. 3/4). 10-fold cross validation was used to evaluate model performance. Results: Before stratification by tumor grade and stage, radiomics predicted the presence of several biomarkers with weak discrimination (AUC 0.60–0.68). Once stratified, radiomics predicted KDM5C, SETD2, PBRM1, and mTOR mutation status with acceptable to excellent predictive discrimination (AUC ranges from 0.70 to 0.86). Conclusions: Radiomic texture analysis can potentially identify a variety of clinically relevant biomarkers in patients with ccRCC and may have a prognostic implication.

          Related collections

          Author and article information

          Journal
          OCL
          Oncology
          10.1159/issn.0030-2414
          Oncology
          Oncology
          S. Karger AG
          0030-2414
          1423-0232
          2023
          June 2023
          20 April 2023
          : 101
          : 6
          : 375-388
          Affiliations
          [_a] aKeck School of Medicine, University of Southern California, Los Angeles, California, USA
          [_b] bDepartment of Radiology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA
          [_c] cDepartment of Biochemistry and Molecular Medicine, University of Southern California, Los Angeles, California, USA
          [_d] dRadiology Associates of San Luis Obispo, Atascadero, California, USA
          [_e] eDepartment of Medicine, University of Southern California, Los Angeles, California, USA
          [_f] fDepartment of Pathology, University of Southern California, Los Angeles, California, USA
          [_g] gDepartment of Medicine, University of Michigan, Ann Arbor, Michigan, USA
          [_h] hDepartment of Neurology, University of Southern California, Los Angeles, California, USA
          [_i] iInstitute of Urology, University of Southern California, Los Angeles, California, USA
          [_j] jDepartment of Biomedical Engineering, University of Southern California, Los Angeles, California, USA
          Author notes
          *Bino A Varghese, bino.varghese@med.usc.edu
          Author information
          https://orcid.org/0000-0003-1803-2134
          https://orcid.org/0000-0002-1411-0417
          Article
          530719 Oncology 2023;101:375–388
          10.1159/000530719
          37080171
          57014cf7-ebaa-4d93-8bf5-6d7cc9fb6392
          © 2023 The Author(s). Published by S. Karger AG, Basel

          This article is licensed under the Creative Commons Attribution 4.0 International License (CC BY). Usage, derivative works and distribution are permitted provided that proper credit is given to the author and the original publisher.

          History
          : 22 November 2022
          : 23 March 2023
          Page count
          Figures: 6, Tables: 4, Pages: 14
          Funding
          This work was supported in part by funding from the Radiological Society of North America (RSNA) and in part by funding from the Southern California Clinical and Translational Science Institute (SC-CTSI).
          Categories
          Clinical Translational Research

          Medicine
          Radiomics,Radiogenomics,Machine learning,Clear cell renal cell carcinoma
          Medicine
          Radiomics, Radiogenomics, Machine learning, Clear cell renal cell carcinoma

          Comments

          Comment on this article